Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15138714rdf:typepubmed:Citationlld:pubmed
pubmed-article:15138714lifeskim:mentionsumls-concept:C0032854lld:lifeskim
pubmed-article:15138714lifeskim:mentionsumls-concept:C0334634lld:lifeskim
pubmed-article:15138714lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:15138714lifeskim:mentionsumls-concept:C0243095lld:lifeskim
pubmed-article:15138714lifeskim:mentionsumls-concept:C1413172lld:lifeskim
pubmed-article:15138714lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:15138714lifeskim:mentionsumls-concept:C2599665lld:lifeskim
pubmed-article:15138714lifeskim:mentionsumls-concept:C1561558lld:lifeskim
pubmed-article:15138714lifeskim:mentionsumls-concept:C0522498lld:lifeskim
pubmed-article:15138714pubmed:issue9lld:pubmed
pubmed-article:15138714pubmed:dateCreated2004-9-27lld:pubmed
pubmed-article:15138714pubmed:abstractTextA patient with mantle cell lymphoma (MCL) of the pleomorphic blastoid subtype is reported. The disease was clinically aggressive and refractory to chemotherapy, and the patient survived only 2 months. Cytogenetically, a t(11;19;14)(q13;q13;q32) was found. Fluorescent in situ hybridization (FISH) and molecular analyses demonstrated involvement of the BCL1/CCND1 locus in a three-way translocation. In addition, subclonal abnormalities of the region 8q24 manifested either as a t(8;22)(q24;q11)/CMYC rearrangement or trisomy 8 were identified. The pathogenetic impact of this very uncommon association of BCL1/CCND1 and CMYC rearrangements in MCL is discussed and the literature is reviewed.lld:pubmed
pubmed-article:15138714pubmed:languageenglld:pubmed
pubmed-article:15138714pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15138714pubmed:citationSubsetIMlld:pubmed
pubmed-article:15138714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15138714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15138714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15138714pubmed:statusMEDLINElld:pubmed
pubmed-article:15138714pubmed:monthSeplld:pubmed
pubmed-article:15138714pubmed:issn0939-5555lld:pubmed
pubmed-article:15138714pubmed:authorpubmed-author:HagemeijerAAlld:pubmed
pubmed-article:15138714pubmed:authorpubmed-author:FerrantAAlld:pubmed
pubmed-article:15138714pubmed:authorpubmed-author:WlodarskaIIlld:pubmed
pubmed-article:15138714pubmed:authorpubmed-author:MichauxLLlld:pubmed
pubmed-article:15138714pubmed:authorpubmed-author:StulMMlld:pubmed
pubmed-article:15138714pubmed:authorpubmed-author:DeneysVVlld:pubmed
pubmed-article:15138714pubmed:authorpubmed-author:TheateIIlld:pubmed
pubmed-article:15138714pubmed:authorpubmed-author:ScheiffJ-MJMlld:pubmed
pubmed-article:15138714pubmed:issnTypePrintlld:pubmed
pubmed-article:15138714pubmed:volume83lld:pubmed
pubmed-article:15138714pubmed:ownerNLMlld:pubmed
pubmed-article:15138714pubmed:authorsCompleteYlld:pubmed
pubmed-article:15138714pubmed:pagination578-83lld:pubmed
pubmed-article:15138714pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:meshHeadingpubmed-meshheading:15138714...lld:pubmed
pubmed-article:15138714pubmed:year2004lld:pubmed
pubmed-article:15138714pubmed:articleTitleCoexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome.lld:pubmed
pubmed-article:15138714pubmed:affiliationDepartment of Hematology, Clinical Biology and Pathology, Cliniques universitaires UCL St Luc, Brussels, Belgium.lld:pubmed
pubmed-article:15138714pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15138714pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:15138714pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:595entrezgene:pubmedpubmed-article:15138714lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15138714lld:entrezgene